Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lydakis, C.
Right arrow Articles by Lip, G. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lydakis, C.
Right arrow Articles by Lip, G. Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

QJM, Vol 91, Issue 6 381-391, Copyright © 1998 by Oxford University Press

REVIEWS

Microalbuminuria and cardiovascular risk

C Lydakis and GY Lip
University Department of Medicine, City Hospital, Birmingham, UK. greg@chtmedicine.demon.co.uk

The term 'microalbuminuria' has been introduced to describe a measurable increase in urine albumin excretion, which is still within normal total urine protein excretion levels. Many data suggest that microalbuminuria is of value as an index of vascular damage, especially in hypertension and diabetes, and there is increasing information on its associations with traditional cardiovascular risk factors and its prognostic value. The association between microalbuminuria and peripheral markers of endothelial damage or dysfunction, such as von Willebrand factor, suggests the possibility that microalbuminuria may be a simple, cheap and easy index of endothelial abnormalities in cardiovascular disease. Nevertheless, further information on the value of microalbuminuria in other atherosclerotic vascular complications, such as ischaemic heart disease, stroke and peripheral artery disease is still needed.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Occup. Environ. Med.Home page
M S O'Neill, A V Diez-Roux, A H Auchincloss, T G Franklin, D R Jacobs Jr, B C Astor, J T Dvonch, and J Kaufman
Airborne particulate matter exposure and urinary albumin excretion: the Multi-Ethnic Study of Atherosclerosis
Occup. Environ. Med., August 1, 2008; 65(8): 534 - 540.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
B. Mukhopadhyay, N. Sattar, and M. Fisher
Review: Diabetes and cardiac disease in South Asians
The British Journal of Diabetes & Vascular Disease, September 1, 2005; 5(5): 253 - 259.
[Abstract] [PDF]

Home page
 Clin. Chem.Home page
Q.-P. Qin, O. Peltola, and K. Pettersson
Time-resolved Fluorescence Resonance Energy Transfer Assay for Point-of-Care Testing of Urinary Albumin
Clin. Chem., July 1, 2003; 49(7): 1105 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. Yorgancioglu, H. Tokmakoglu, K. Suzer, and Y. Zorlutuna
Does microalbuminuria in diabetic patients affect the postoperative course after coronary artery bypass surgery?
Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 395 - 400.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.